NASDAQ:ORTX
Delisted

Orchard Therapeutics Stock Predictions

etoro logo Buy ORTX
*Your capital is at risk
$16.70
+0 (+0%)
At Close: Mar 15, 2024
Currently predicting for Mon, 8 Jun 2026

ORTX Prediction Chart

ORTX Predictions History

Latest community submissions for ORTX.
Predictor Target Session Target Price Result Direction Accuracy Score
AlexVel AlexVel Pro
Feb 6, 2024 $16.69 -0.06% $16.70 X 99.94% 9
AlexVel AlexVel Pro
Feb 5, 2024 $16.69 -0.03% $16.70 X 99.97% 9
AlexVel AlexVel Pro
Feb 2, 2024 $16.69 -0.04% $16.70 X 99.96% 9
AlexVel AlexVel Pro
Feb 1, 2024 $16.70 -0.01% $16.70 X 99.99% 9
AlexVel AlexVel Pro
Jan 26, 2024 $16.69 -0.06% $16.70 X 99.94% 9
AlexVel AlexVel Pro
Jan 25, 2024 $16.71 +0.06% $16.70 X 99.94% 9
AlexVel AlexVel Pro
Jan 24, 2024 $16.73 +0.18% $16.70 X 99.82% 5
AlexVel AlexVel Pro
Jan 22, 2024 $16.58 -0.18% $16.65 X 99.58% 4
AlexVel AlexVel Pro
Jan 19, 2024 $16.54 -0.18% $16.61 X 99.58% 4
AlexVel AlexVel Pro
Jan 18, 2024 $16.51 -0.24% $16.57 X 99.64% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ORTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ORCHARD THERAPEUTICS PLC
Orchard Therapeutics
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE